Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Obstet Gynecol. 2010 Nov;203(5):457.e1-9. doi: 10.1016/j.ajog.2010.06.044. Epub 2010 Aug 24.

Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis.

Author information

1
Department of Obstetrics and Gynecology, Jessop Wing, Sheffield Teaching Hospital National Health Service Trust, Sheffield, England, United Kingdom. doc15jaya@yahoo.co.uk

Abstract

OBJECTIVE:

The objective of this review was to provide pooled estimates of randomized controlled trials comparing the effects of oral hypoglycemic agents with insulin in achieving glycemic control and to study the maternal and perinatal outcomes in gestational diabetes mellitus.

STUDY DESIGN:

A protocol for the study was developed. All metaanalyses were performed using Stats Direct statistical software (Stats Direct Ltd, Cheshire, UK).

RESULTS:

Six studies comprising 1388 subjects were analyzed. No significant differences were found in maternal fasting (weighted mean difference [WMD], 1.31; 95% confidence interval [CI], 0.81-3.43) or postprandial (WMD, 0.80; 95% CI, -3.26 to 4.87) glycemic control. Use of oral hypoglycemic agents (OHAs) was not associated with risk of neonatal hypoglycemia (odds ratio [OR], 1.59; 95% CI, 0.70-3.62), increased birthweight (WMD, 56.11; 95% CI, -42.62 to 154.84), incidence of caesarean section (OR, 0.91; 95% CI, -0.68 to 1.22), or incidence of large-for-gestational-age babies (OR, 1.01; 95% CI, 0.61-1.68).

CONCLUSION:

Our study demonstrates that there are no differences in glycemic control or pregnancy outcomes when OHAs were compared with insulin.

PMID:
20739011
DOI:
10.1016/j.ajog.2010.06.044
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Health
    Loading ...
    Support Center